Global and U.S. STD Case Counts
Each year, millions of new sexually transmitted infections are recorded worldwide, with the United States accounting for a large share of reported cases. The Centers for Disease Control and Prevention publishes annual surveillance data that tracks bacterial, viral, and parasitic STDs across all states and territories. In recent reporting cycles, the CDC documented that chlamydia remains the most commonly reported infectious disease in the U.S., followed by gonorrhea and primary and secondary syphilis. Global estimates from the World Health Organization indicate hundreds of millions of new curable STDs occur annually, with the highest burden in low- and middle-income regions where testing access is limited. For context on how these numbers are compiled and verified, see the CDC's Sexually Transmitted Infections Surveillance report.
In the U.S., state and local health departments collect case reports from laboratories and clinicians, which are then aggregated by the CDC into national totals. The CDC's National Notifiable Diseases Surveillance System captures data on more than a dozen STDs, including chlamydia, gonorrhea, syphilis, and HIV. Recent years have shown fluctuations in case counts, with some infections declining after pandemic-era disruptions and others rebounding as screening and reporting return to normal levels. The WHO's Global Health Observatory provides comparable international statistics, helping researchers and policymakers compare incidence rates across regions and track progress toward global health targets.
Trends by Infection Type
Chlamydia trachomatis infections consistently account for the largest share of reported STD cases in the U.S., with millions of new diagnoses each year. Gonorrhea cases have risen in recent cycles, driven in part by antimicrobial resistance and changes in screening practices. Primary and secondary syphilis, while less common than chlamydia and gonorrhea, has seen sharp increases, particularly among certain demographic groups and in specific geographic areas. Congenital syphilis, transmitted from mother to child during pregnancy, has also surged, prompting public health alerts and expanded prenatal screening recommendations. Detailed breakdowns of these trends are available in the CDC's latest STD surveillance figures.
Viral STDs such as human papillomavirus, herpes simplex virus, and HIV are tracked differently because many infections are asymptomatic or go undiagnosed. HPV is the most common STD worldwide, with the majority of sexually active people acquiring it at some point, though most infections clear on their own. HIV incidence in the U.S. has declined overall due to expanded testing, pre-exposure prophylaxis, and antiretroviral therapy, but disparities persist by race, gender, and geography. The WHO and UNAIDS publish annual estimates on HIV and viral hepatitis, which are often grouped with STDs in global burden analyses.
Implications for Public Health and Policy
High annual STD case counts strain healthcare systems, requiring sustained investment in testing, treatment, contact tracing, and public education. The CDC and state health departments use surveillance data to allocate resources, target interventions, and evaluate the effectiveness of prevention programs. Recent federal and private-sector initiatives have focused on expanding access to rapid testing, telehealth consultations, and at-home screening kits to reach underserved populations. Pharmaceutical companies and nonprofit organizations also collaborate on vaccine development for STDs like HPV and HIV, aiming to reduce long-term incidence.
Policy responses to rising STD numbers include updated screening guidelines, increased funding for public health infrastructure, and campaigns to reduce stigma around testing and treatment. The Affordable Care Act and other insurance expansions have improved coverage for STD screenings, though access gaps remain in rural and low-income areas. International organizations such as the WHO coordinate global strategies to combat STDs, setting targets for reduction and monitoring progress through annual reports. For a broader view of how public health agencies track and respond to these trends, see the World Health Organization's fact sheet on sexually transmitted infections.